Literature DB >> 25010963

Whooping cough in 2014 and beyond: an update and review.

Joshua D Hartzell1, Jason M Blaylock2.   

Abstract

Pertussis, or whooping cough, has had a dramatic resurgence in the past several years and is the most common vaccine-preventable disease in the world. The year 2012 marked the most cases in the United States in > 50 years. Large outbreaks have occurred in multiple states, and infant deaths have drawn the attention of not only health-care providers but also the media. Although the disease is theoretically preventable by vaccination, it remains a challenge to control. New vaccination strategies have been implemented across different age groups and populations of patients, but vaccine coverage remains dismally low. Acellular vaccines, although safe, do not afford the same long-lasting immunity as the previously used whole-cell vaccine. Ultimately, improvements in the development of vaccines and in vaccination coverage will be essential to decrease the burden of pertussis on society. This article provides a review of pertussis infection and discusses advances related to the epidemiology, diagnosis, treatment, and prevention of infection, as well as continued areas of uncertainty.

Entities:  

Mesh:

Year:  2014        PMID: 25010963     DOI: 10.1378/chest.13-2942

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

Review 1.  [Recent progress in clinical research on pertussis].

Authors:  Dan-Xia Wu; Qiang Chen; Kun-Ling Shen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

2.  [Clinical value of cleaved lymphocytes in assisting the diagnosis of pertussis in children].

Authors:  Xiu-Zhuang Xu; Jin-Can Zhang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

3.  Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets.

Authors:  Shokrollah Elahi; David R Thompson; Jill Van Kessel; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

4.  Differences in innate IFNγ and IL-17 responses to Bordetella pertussis between BALB/c and C57BL/6 mice: role of γδT cells, NK cells, and dendritic cells.

Authors:  Yung-Yi C Mosley; Fangjia Lu; Harm HogenEsch
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

5.  Complete genome sequence of a clinical Bordetella pertussis isolate from Brazil.

Authors:  Bruno Gabriel N Andrade; Michel F Abanto Marin; Diego Duque Cambuy; Erica Lourenço Fonseca; Nadjla Ferreira Souza; Ana Carolina P Vicente
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-11       Impact factor: 2.743

6.  CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis.

Authors:  Afshin Namdar; Petya Koleva; Shima Shahbaz; Stacy Strom; Volker Gerdts; Shokrollah Elahi
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

7.  Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco.

Authors:  Khalid Katfy; Idrissa Diawara; Fakhredine Maaloum; Siham Aziz; Nicole Guiso; Hassan Fellah; Bouchra Slaoui; Khalid Zerouali; Houria Belabbes; Naima Elmdaghri
Journal:  BMC Infect Dis       Date:  2020-01-14       Impact factor: 3.090

Review 8.  Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in the Middle East.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-04-27

Review 9.  Systems Biology Approaches for Therapeutics Development Against COVID-19.

Authors:  Shweta Jaiswal; Mohit Kumar; Yogendra Singh; Pratyoosh Shukla
Journal:  Front Cell Infect Microbiol       Date:  2020-10-28       Impact factor: 5.293

10.  Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013.

Authors:  Josep Alvarez; Pere Godoy; Pedro Plans-Rubio; Neus Camps; Monica Carol; Gloria Carmona; Ruben Solano; Cristina Rius; Sofia Minguell; Irene Barrabeig; Maria R Sala-Farré; Raquel Rodriguez; Manuel Garcia-Cenoz; Carmen Muñoz-Almagro; Angela Dominguez
Journal:  Emerg Infect Dis       Date:  2020-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.